Lars Henrik Høie
Plus aucun poste en cours
Profil
Lars Henrik Høie was the founder of Nutri Pharma ASA, which was founded in 1993, where he held the title of Research Director.
He was also the Chairman of Bionor Pharma ASA from 2011 to 2016.
Dr. Høie received a doctorate degree from the University of Oslo in 2011.
Anciens postes connus de Lars Henrik Høie
| Sociétés | Poste | Fin |
|---|---|---|
Nutri Pharma ASA
 Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway | Founder | - |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Chairman | - |
Formation de Lars Henrik Høie
| University of Oslo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nutri Pharma ASA
Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway | Commercial Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
